Generation Market Cap from 2010 to 2024

GBIO Stock  USD 2.70  0.22  7.53%   
Generation Bio Market Cap yearly trend continues to be very stable with very little volatility. Market Cap is likely to drop to about 249.5 M. During the period from 2010 to 2024, Generation Bio Market Cap quarterly data regression pattern had sample variance of 49269.8 T and median of  486,208,961. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
262.7 M
Current Value
249.5 M
Quarterly Volatility
222 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Generation Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Generation Bio's main balance sheet or income statement drivers, such as Net Interest Income of 12.5 M, Interest Income of 12.5 M or Depreciation And Amortization of 3.8 M, as well as many indicators such as Price To Sales Ratio of 19.69, Dividend Yield of 0.0 or PTB Ratio of 0.55. Generation financial statements analysis is a perfect complement when working with Generation Bio Valuation or Volatility modules.
  
Check out the analysis of Generation Bio Correlation against competitors.

Latest Generation Bio's Market Cap Growth Pattern

Below is the plot of the Market Cap of Generation Bio Co over the last few years. It is Generation Bio's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Generation Bio's overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Pretty Stable
   Market Cap   
       Timeline  

Generation Market Cap Regression Statistics

Arithmetic Mean495,249,421
Geometric Mean457,255,487
Coefficient Of Variation44.82
Mean Deviation123,097,439
Median486,208,961
Standard Deviation221,967,943
Sample Variance49269.8T
Range912.6M
R-Value(0.18)
Mean Square Error51385.5T
R-Squared0.03
Significance0.53
Slope(8,816,756)
Total Sum of Squares689776.7T

Generation Market Cap History

2024249.5 M
2023262.7 M
2022228.4 M
2021398.6 M
2020772.7 M
20191.1 B

About Generation Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Generation Bio income statement, its balance sheet, and the statement of cash flows. Generation Bio investors use historical funamental indicators, such as Generation Bio's Market Cap, to determine how well the company is positioned to perform in the future. Although Generation Bio investors may use each financial statement separately, they are all related. The changes in Generation Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Generation Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Generation Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Generation Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Market Cap262.7 M249.5 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Generation Stock

When determining whether Generation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Generation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Generation Bio Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Generation Bio Co Stock:
Check out the analysis of Generation Bio Correlation against competitors.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.55)
Revenue Per Share
0.151
Return On Assets
(0.22)
Return On Equity
(0.82)
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.